<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04191265</url>
  </required_header>
  <id_info>
    <org_study_id>cardiotoxicity of ALP cases</org_study_id>
    <nct_id>NCT04191265</nct_id>
  </id_info>
  <brief_title>Cardiotoxicity of Aluminum Phosphide Poisoning; Tropinin and CKmb as Early Biomarkers</brief_title>
  <official_title>Cardiotoxicity of Aluminum Phosphide Poisoning; Biochemical and Electrophysiological Studies and the Utility of Tropinin and CKmb as Early Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aluminum phosphide (AlP) or rice tablet is a cheap pesticide. When it comes in contact with
      acid (gastric acid) or moisture, it releases phosphine (PH3) gas. The heart,lungs, liver are
      the main targets in acute Aluminum phosphide (AlP) poisoning. Most deaths occur due to
      cardiovascular toxicity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aluminium phosphide is a potent respiratory chain enzyme inhibitor. Its most important effect
      is the inhibition of cytochrome c oxidase. The inhibition of cytochrome c oxidase and other
      enzymes leads to the generation of superoxide radicals and cellular peroxides , and
      subsequent cellular injury through lipid peroxidation and other oxidant mechanisms. It
      stimulates the production of hydrogen peroxide and reactive oxygen species, malonyldialdehyde
      (MAD), increases superoxide dismutase and inhibits catalase, peroxidase and glutathione .
      Oxidative stress is one of the main mechanisms of action of aluminium phosphide toxicity
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 5, 2019</start_date>
  <completion_date type="Anticipated">June 5, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 5, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>assess serum tropinin and CKmb as biomarkers for early detection of ALP induced myocardial injury</measure>
    <time_frame>6 months</time_frame>
    <description>assess serum tropinin and CKmb as biomarkers for early detection of ALP induced myocardial injury</description>
  </primary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Cardiotoxicity</condition>
  <condition>Aluminum Phosphid Poisoning</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>serum tropinin, serum CKmb</intervention_name>
    <description>early detection of myocardial injury, allowing application of acute cardiac shock and cardiogenic shock</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Assiut governorate
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: ALP poisoned cases

          -  admitted with free ECG

        Exclusion Criteria:

        concomitant ingesion of other drugs or toxins

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Doaa</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Doaa Mohamed Abd El-Rahman</investigator_full_name>
    <investigator_title>Assiut University</investigator_title>
  </responsible_party>
  <keyword>tropinin</keyword>
  <keyword>CKmb</keyword>
  <keyword>cardiotoxicity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiotoxicity</mesh_term>
    <mesh_term>Poisoning</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

